Protocols for High-Risk Pregnancies. Группа авторов
36.4 Work‐up and management of pancreatitis in pregnancy
19 Chapter 38Figure 38.1 Treatment algorithm for nausea and vomiting in pregnancy.
20 Chapter 41Figure 41.1 Management of fetal growth restriction.
21 Chapter 42Figure 42.1 Algorithm for the management of the red cell alloimmunized pregn...
22 Chapter 43Figure 43.1 A proposed algorithm for combined cervical length (CL) and fetal...
23 Chapter 44Figure 44.1 Care pathways to reduce risk of preterm birth.
24 Chapter 46Figure 46.1 Proposed approach for determination of gestational age.
25 Chapter 47Figure 47.1 Isolated maternal fever.Figure 47.2 Diagnosis of triple I.
26 Chapter 48Figure 48.1 Management of third‐trimester bleeding due to placenta previa.Figure 48.2 Types of vasa previa.Figure 48.3 Ultrasound diagnosis of vasa previa via transvaginal imaging and...Figure 48.4 Management of third‐trimester bleeding.
27 Chapter 49Figure 49.1 Acute management of AFE.
28 Chapter 50Figure 50.1 Signs and symptoms of preeclampsia and organ dysfunction.Figure 50.2 Recommended management of gestational hypertension or preeclamps...Figure 50.3 Recommended management of preeclampsia with severe features <34w...
29 Chapter 52Figure 52.1 Moderate variability.Figure 52.2 Late decelerations.Figure 52.3 Variable decelerations.Figure 52.4 Sinusoidal pattern.Figure 52.5 Fetal oxygenation.Figure 52.6 Two central principles of electronic intrapartum fetal heart rat...Figure 52.7 Intrapartum FHR monitoring management decision algorithm.
30 Chapter 54Figure 54.1 Odds ratio graph comparing morbidity of trial of labor with elec...Figure 54.2 Flow chart showing one management scheme for vaginal birth after...
31 Chapter 58Figure 58.1 Algorithm for postpartum hemorrhage. BP, blood pressure; CS, ces...
32 Appendix AFigure A.1 Timeline of prenatal genetic screening and diagnostic testing opt...Figure A.2 Nuchal translucency measurements between 11 and 14 weeks of gesta...Figure A.3 Prevalence of trisomies 21, 18, and 13 according to maternal age ...Figure A.4 Amniotic fluid ΔOD450 management zones.Figure A.5 Middle cerebral artery (MCA) Doppler peak velocities. Peak MCA Do...
Guide
4 Preface
8 Appendix A Evaluation of Fetal Health and Defects
9 Index
10 WILEY END USER LICENSE AGREEMENT
Pages
1 iii
2 iv
3 ix
4 xi
5 xii
6 xiii
7 xiv
8 xv
9 1
10 3
11 4
12 5
13 6
14 7
15 8
16 9
17 10
18 11
19 12
20 13
21 14
22 15
23 16
24 17
25 18
26 19
27 20
28 21
29 22
30 23
31 24
32 25
33 27
34 29
35 30